The North America contract research organization (CRO) market is expected to reach US$ 30.7 Bn in 2025 from US$ 16.3 Bn in 2017. The market is estimated to grow with a CAGR of 8.4% from 2018-2025.
The growth of the Contract Research Organization (CRO) market is driven by the factors such as, increasing R&D expenditures and outsourcing activities and rise in the number of clinical trials. However, the market is likely to get impacted due to dearth of skilled professionals and regional competition in the CRO services market, in the region.
Pharmaceutical and biotech companies are focusing on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$ 49.6 Bn 2012 to US$ 58.8 Bn in 2015. Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch. According to the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology industry grew by approximately 8.7% than that of the expenditures in 2013. Moreover, in United States, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in US it accounted approximately 17% and in the European Union it was registered to be approximately 13% in the year 2014. Therefore, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) in order to save the cost and time which is expected to drive the growth of the market.
US is expected to lead the market in the North America region owing to increasing expenditure of research and development expenditures in the country. The confrontation of biotechnology and pharmaceutical companies to lower the drug development costs is expected to propel the CROs market in the US. Moreover, the presence of top revenue generating pharmaceutical companies in the US that have capability to invest a large amount in R&D is also expected to boost the growth of CROs in the US. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
Mexico Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) – MARKET SEGMENTATION
NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) – By Type
- Clinical Research Services
- Early Phase Development Services
- Laboratory Services
- Post-Approval Services
NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) – By End User
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) – By Geography
• North America
- US
- Canada
- Mexico
Company Profiles
- IQVIA
- Laboratory Corporation of America Holdings
- PAREXEL International Corporation
- ICON plc
- Syneos Health
- PRA Health Sciences
- Charles River
- Pharmaceutical Product Development, LLC
- WuXi AppTec
- Medpace
North America Contract Research Organization (CRO) Report Scope
Report Attribute | Details |
---|---|
Market size in 2017 | US$ 16.3 Billion |
Market Size by 2025 | US$ 30.7 Billion |
Global CAGR (2018 - 2025) | 8.4% |
Historical Data | 2015-2016 |
Forecast period | 2018-2025 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies
- IQVIA
- Laboratory Corporation of America Holdings
- PAREXEL International Corporation
- ICON plc
- Syneos Health
- PRA Health Sciences
- Charles River
- Pharmaceutical Product Development, LLC
- WuXi AppTec
- Medpace


